C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus Article Swipe
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0147303
In this study, we investigate how measures of insulin secretion and other clinical information affect long-term glycemic control in patients with type 2 diabetes mellitus. Between October 2012 and June 2014, we monitored 202 diabetes patients who were admitted to the hospital of Asahi Life Foundation for glycemic control, as well as for training and education in diabetes management. We measured glycated hemoglobin (HbA1c) six months after discharge to assess disease management. In univariate analysis, fasting plasma C-peptide immunoreactivity (F-CPR) and pooled urine CPR (U-CPR) were significantly associated with HbA1c, in contrast to ΔCPR and C-peptide index (CPI). This association was strongly independent of most other patient variables. In exploratory factor analysis, five underlying factors, namely insulin resistance, aging, sex differences, insulin secretion, and glycemic control, represented patient characteristics. In particular, insulin secretion and resistance strongly influenced F-CPR, while insulin secretion affected U-CPR. In conclusion, the data indicate that among patients with type 2 diabetes mellitus, F-CPR and U-CPR may predict improved glycemic control six months after hospitalization.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1371/journal.pone.0147303
- https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printable
- OA Status
- gold
- Cited By
- 14
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2272539536
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2272539536Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1371/journal.pone.0147303Digital Object Identifier
- Title
-
C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes MellitusWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2016Year of publication
- Publication date
-
2016-02-05Full publication date if available
- Authors
-
Remi Sonoda, Kentaro Tanaka, Takako Kikuchi, Yukiko Onishi, Toshiko Takao, Tazu Tahara, Yoko Yoshida, Naoki Suzawa, Shoji Kawazu, Yasuhiko Iwamoto, Akifumi KushiyamaList of authors in order
- Landing page
-
https://doi.org/10.1371/journal.pone.0147303Publisher landing page
- PDF URL
-
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printableDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printableDirect OA link when available
- Concepts
-
Medicine, Glycemic, Diabetes mellitus, Internal medicine, Glycated hemoglobin, Type 2 Diabetes Mellitus, Insulin resistance, C-peptide, Insulin, Type 1 diabetes, Univariate analysis, Type 2 diabetes, Endocrinology, Multivariate analysisTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
14Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1, 2021: 3, 2020: 2, 2019: 2, 2018: 4Per-year citation counts (last 5 years)
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2272539536 |
|---|---|
| doi | https://doi.org/10.1371/journal.pone.0147303 |
| ids.doi | https://doi.org/10.1371/journal.pone.0147303 |
| ids.mag | 2272539536 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/26849676 |
| ids.openalex | https://openalex.org/W2272539536 |
| fwci | 2.01988479 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000368 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Aged |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D015415 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Biomarkers |
| mesh[2].qualifier_ui | Q000097 |
| mesh[2].descriptor_ui | D002096 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | blood |
| mesh[2].descriptor_name | C-Peptide |
| mesh[3].qualifier_ui | Q000652 |
| mesh[3].descriptor_ui | D002096 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | urine |
| mesh[3].descriptor_name | C-Peptide |
| mesh[4].qualifier_ui | Q000097 |
| mesh[4].descriptor_ui | D003924 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | blood |
| mesh[4].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[5].qualifier_ui | Q000175 |
| mesh[5].descriptor_ui | D003924 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | diagnosis |
| mesh[5].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[6].qualifier_ui | Q000652 |
| mesh[6].descriptor_ui | D003924 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | urine |
| mesh[6].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005215 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Fasting |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D005260 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Female |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006442 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Glycated Hemoglobin |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006760 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Hospitalization |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000378 |
| mesh[12].descriptor_ui | D007328 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | metabolism |
| mesh[12].descriptor_name | Insulin |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000078790 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Insulin Secretion |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008297 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Male |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008875 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Middle Aged |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D012307 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Risk Factors |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000368 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Aged |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D015415 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Biomarkers |
| mesh[19].qualifier_ui | Q000097 |
| mesh[19].descriptor_ui | D002096 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | blood |
| mesh[19].descriptor_name | C-Peptide |
| mesh[20].qualifier_ui | Q000652 |
| mesh[20].descriptor_ui | D002096 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | urine |
| mesh[20].descriptor_name | C-Peptide |
| mesh[21].qualifier_ui | Q000097 |
| mesh[21].descriptor_ui | D003924 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | blood |
| mesh[21].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[22].qualifier_ui | Q000175 |
| mesh[22].descriptor_ui | D003924 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | diagnosis |
| mesh[22].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[23].qualifier_ui | Q000652 |
| mesh[23].descriptor_ui | D003924 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | urine |
| mesh[23].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D005215 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Fasting |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D005260 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Female |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D006442 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Glycated Hemoglobin |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D006760 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Hospitalization |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | Q000378 |
| mesh[29].descriptor_ui | D007328 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | metabolism |
| mesh[29].descriptor_name | Insulin |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000078790 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Insulin Secretion |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008297 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Male |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008875 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Middle Aged |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D012307 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Risk Factors |
| type | article |
| title | C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus |
| biblio.issue | 2 |
| biblio.volume | 11 |
| biblio.last_page | e0147303 |
| biblio.first_page | e0147303 |
| topics[0].id | https://openalex.org/T11623 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Hyperglycemia and glycemic control in critically ill and hospitalized patients |
| topics[1].id | https://openalex.org/T11171 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9994000196456909 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Diabetes and associated disorders |
| topics[2].id | https://openalex.org/T10560 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9987000226974487 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Diabetes Management and Research |
| is_xpac | False |
| apc_list.value | 1805 |
| apc_list.currency | USD |
| apc_list.value_usd | 1805 |
| apc_paid.value | 1805 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1805 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8350478410720825 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780473172 |
| concepts[1].level | 3 |
| concepts[1].score | 0.826964259147644 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5572518 |
| concepts[1].display_name | Glycemic |
| concepts[2].id | https://openalex.org/C555293320 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6911727786064148 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[2].display_name | Diabetes mellitus |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6732558608055115 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2777538456 |
| concepts[4].level | 4 |
| concepts[4].score | 0.6435323357582092 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q311213 |
| concepts[4].display_name | Glycated hemoglobin |
| concepts[5].id | https://openalex.org/C2910068830 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5321499705314636 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[5].display_name | Type 2 Diabetes Mellitus |
| concepts[6].id | https://openalex.org/C2777391703 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5296266674995422 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1053470 |
| concepts[6].display_name | Insulin resistance |
| concepts[7].id | https://openalex.org/C2778875212 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5061952471733093 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q419107 |
| concepts[7].display_name | C-peptide |
| concepts[8].id | https://openalex.org/C2779306644 |
| concepts[8].level | 2 |
| concepts[8].score | 0.49245890974998474 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2002370 |
| concepts[8].display_name | Insulin |
| concepts[9].id | https://openalex.org/C2781232474 |
| concepts[9].level | 3 |
| concepts[9].score | 0.48617738485336304 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q124407 |
| concepts[9].display_name | Type 1 diabetes |
| concepts[10].id | https://openalex.org/C144301174 |
| concepts[10].level | 3 |
| concepts[10].score | 0.47589409351348877 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7893852 |
| concepts[10].display_name | Univariate analysis |
| concepts[11].id | https://openalex.org/C2777180221 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4520060420036316 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[11].display_name | Type 2 diabetes |
| concepts[12].id | https://openalex.org/C134018914 |
| concepts[12].level | 1 |
| concepts[12].score | 0.45057374238967896 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[12].display_name | Endocrinology |
| concepts[13].id | https://openalex.org/C38180746 |
| concepts[13].level | 2 |
| concepts[13].score | 0.15558922290802002 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1952580 |
| concepts[13].display_name | Multivariate analysis |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8350478410720825 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/glycemic |
| keywords[1].score | 0.826964259147644 |
| keywords[1].display_name | Glycemic |
| keywords[2].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[2].score | 0.6911727786064148 |
| keywords[2].display_name | Diabetes mellitus |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6732558608055115 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/glycated-hemoglobin |
| keywords[4].score | 0.6435323357582092 |
| keywords[4].display_name | Glycated hemoglobin |
| keywords[5].id | https://openalex.org/keywords/type-2-diabetes-mellitus |
| keywords[5].score | 0.5321499705314636 |
| keywords[5].display_name | Type 2 Diabetes Mellitus |
| keywords[6].id | https://openalex.org/keywords/insulin-resistance |
| keywords[6].score | 0.5296266674995422 |
| keywords[6].display_name | Insulin resistance |
| keywords[7].id | https://openalex.org/keywords/c-peptide |
| keywords[7].score | 0.5061952471733093 |
| keywords[7].display_name | C-peptide |
| keywords[8].id | https://openalex.org/keywords/insulin |
| keywords[8].score | 0.49245890974998474 |
| keywords[8].display_name | Insulin |
| keywords[9].id | https://openalex.org/keywords/type-1-diabetes |
| keywords[9].score | 0.48617738485336304 |
| keywords[9].display_name | Type 1 diabetes |
| keywords[10].id | https://openalex.org/keywords/univariate-analysis |
| keywords[10].score | 0.47589409351348877 |
| keywords[10].display_name | Univariate analysis |
| keywords[11].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[11].score | 0.4520060420036316 |
| keywords[11].display_name | Type 2 diabetes |
| keywords[12].id | https://openalex.org/keywords/endocrinology |
| keywords[12].score | 0.45057374238967896 |
| keywords[12].display_name | Endocrinology |
| keywords[13].id | https://openalex.org/keywords/multivariate-analysis |
| keywords[13].score | 0.15558922290802002 |
| keywords[13].display_name | Multivariate analysis |
| language | en |
| locations[0].id | doi:10.1371/journal.pone.0147303 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S202381698 |
| locations[0].source.issn | 1932-6203 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1932-6203 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | PLoS ONE |
| locations[0].source.host_organization | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_name | Public Library of Science |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315706 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printable |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | PLOS ONE |
| locations[0].landing_page_url | https://doi.org/10.1371/journal.pone.0147303 |
| locations[1].id | pmid:26849676 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | PloS one |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/26849676 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:4743946 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://doi.org/10.1371/journal.pone.0147303 |
| locations[3].id | pmh:oai:doaj.org/article:a3ebbd64f2fd40ba8ee9948c7cfb7f1a |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | PLoS ONE, Vol 11, Iss 2, p e0147303 (2016) |
| locations[3].landing_page_url | https://doaj.org/article/a3ebbd64f2fd40ba8ee9948c7cfb7f1a |
| locations[4].id | pmh:oai:figshare.com:article/2596498 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400572 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[4].source.host_organization | https://openalex.org/I196829312 |
| locations[4].source.host_organization_name | La Trobe University |
| locations[4].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[4].license | cc-by |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Dataset |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://figshare.com/articles/dataset/C_Peptide_Level_in_Fasting_Plasma_and_Pooled_Urine_Predicts_HbA1c_after_Hospitalization_in_Patients_with_Type_2_Diabetes_Mellitus/2596498 |
| locations[5].id | pmh:oai:RePEc:plo:pone00:0147303 |
| locations[5].is_oa | False |
| locations[5].source.id | https://openalex.org/S4306401271 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | RePEc: Research Papers in Economics |
| locations[5].source.host_organization | https://openalex.org/I77793887 |
| locations[5].source.host_organization_name | Federal Reserve Bank of St. Louis |
| locations[5].source.host_organization_lineage | https://openalex.org/I77793887 |
| locations[5].license | |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | article |
| locations[5].license_id | |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147303 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5065980264 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Remi Sonoda |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[0].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[0].institutions[0].type | other |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Remi Sonoda |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[1].author.id | https://openalex.org/A5106134531 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Kentaro Tanaka |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[1].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[1].institutions[0].type | other |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kentaro Tanaka |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[2].author.id | https://openalex.org/A5076072349 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5099-7203 |
| authorships[2].author.display_name | Takako Kikuchi |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[2].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[2].institutions[0].type | other |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Takako Kikuchi |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[3].author.id | https://openalex.org/A5087983151 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1180-5982 |
| authorships[3].author.display_name | Yukiko Onishi |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[3].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[3].institutions[0].type | other |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yukiko Onishi |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[4].author.id | https://openalex.org/A5090154490 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1892-4896 |
| authorships[4].author.display_name | Toshiko Takao |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[4].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[4].institutions[0].type | other |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Toshiko Takao |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[5].author.id | https://openalex.org/A5081065831 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Tazu Tahara |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[5].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[5].institutions[0].type | other |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Tazu Tahara |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[6].author.id | https://openalex.org/A5101677092 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3888-8132 |
| authorships[6].author.display_name | Yoko Yoshida |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[6].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[6].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[6].institutions[0].type | other |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yoko Yoshida |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[7].author.id | https://openalex.org/A5026766293 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Naoki Suzawa |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[7].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[7].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[7].institutions[0].type | other |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Naoki Suzawa |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[8].author.id | https://openalex.org/A5111691008 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Shoji Kawazu |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[8].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[8].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[8].institutions[0].type | other |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Shoji Kawazu |
| authorships[8].is_corresponding | True |
| authorships[8].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[9].author.id | https://openalex.org/A5113655712 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Yasuhiko Iwamoto |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[9].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[9].institutions[0].type | other |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yasuhiko Iwamoto |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[10].author.id | https://openalex.org/A5087631777 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1385-7487 |
| authorships[10].author.display_name | Akifumi Kushiyama |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210087332 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I4210087332 |
| authorships[10].institutions[0].ror | https://ror.org/000hskt11 |
| authorships[10].institutions[0].type | other |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210087332 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | The Institute of Medical Science, Asahi Life Foundation |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Akifumi Kushiyama |
| authorships[10].is_corresponding | True |
| authorships[10].raw_affiliation_strings | Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Chuo-ku, Tokyo, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printable |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11623 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Hyperglycemia and glycemic control in critically ill and hospitalized patients |
| related_works | https://openalex.org/W4210735489, https://openalex.org/W2492679743, https://openalex.org/W2804410467, https://openalex.org/W3010838544, https://openalex.org/W2065380434, https://openalex.org/W2962396696, https://openalex.org/W4229454824, https://openalex.org/W2118518734, https://openalex.org/W2086124810, https://openalex.org/W4386271533 |
| cited_by_count | 14 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2020 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2019 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2018 |
| counts_by_year[4].cited_by_count | 4 |
| counts_by_year[5].year | 2016 |
| counts_by_year[5].cited_by_count | 2 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1371/journal.pone.0147303 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S202381698 |
| best_oa_location.source.issn | 1932-6203 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1932-6203 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | PLoS ONE |
| best_oa_location.source.host_organization | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_name | Public Library of Science |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printable |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | PLOS ONE |
| best_oa_location.landing_page_url | https://doi.org/10.1371/journal.pone.0147303 |
| primary_location.id | doi:10.1371/journal.pone.0147303 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S202381698 |
| primary_location.source.issn | 1932-6203 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1932-6203 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | PLoS ONE |
| primary_location.source.host_organization | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_name | Public Library of Science |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0147303&type=printable |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | PLOS ONE |
| primary_location.landing_page_url | https://doi.org/10.1371/journal.pone.0147303 |
| publication_date | 2016-02-05 |
| publication_year | 2016 |
| referenced_works | https://openalex.org/W1973566943, https://openalex.org/W1994998526, https://openalex.org/W1970952605, https://openalex.org/W2142464164, https://openalex.org/W2166037537, https://openalex.org/W1995626266, https://openalex.org/W1999183830, https://openalex.org/W2139735566, https://openalex.org/W14278876, https://openalex.org/W2752336761, https://openalex.org/W2089373039, https://openalex.org/W2124111875, https://openalex.org/W2014171047, https://openalex.org/W2140602121, https://openalex.org/W1866428512, https://openalex.org/W1824967818, https://openalex.org/W1993283420, https://openalex.org/W2072805325, https://openalex.org/W2027518448, https://openalex.org/W2069702606, https://openalex.org/W2061151388, https://openalex.org/W2021222880, https://openalex.org/W941973657, https://openalex.org/W1563117726, https://openalex.org/W2002668094, https://openalex.org/W2049927786, https://openalex.org/W2167508764, https://openalex.org/W78775556, https://openalex.org/W2158755644, https://openalex.org/W2035795560, https://openalex.org/W4245063811, https://openalex.org/W2042928643, https://openalex.org/W2143660460 |
| referenced_works_count | 33 |
| abstract_inverted_index.2 | 22, 153 |
| abstract_inverted_index.In | 0, 72, 108, 129, 143 |
| abstract_inverted_index.We | 59 |
| abstract_inverted_index.as | 49, 51 |
| abstract_inverted_index.in | 18, 56, 90 |
| abstract_inverted_index.of | 7, 42, 103 |
| abstract_inverted_index.to | 39, 68, 92 |
| abstract_inverted_index.we | 3, 31 |
| abstract_inverted_index.202 | 33 |
| abstract_inverted_index.CPR | 83 |
| abstract_inverted_index.and | 10, 28, 54, 80, 94, 123, 133, 157 |
| abstract_inverted_index.for | 46, 52 |
| abstract_inverted_index.how | 5 |
| abstract_inverted_index.may | 159 |
| abstract_inverted_index.sex | 119 |
| abstract_inverted_index.six | 64, 164 |
| abstract_inverted_index.the | 40, 145 |
| abstract_inverted_index.was | 100 |
| abstract_inverted_index.who | 36 |
| abstract_inverted_index.2012 | 27 |
| abstract_inverted_index.June | 29 |
| abstract_inverted_index.Life | 44 |
| abstract_inverted_index.This | 98 |
| abstract_inverted_index.data | 146 |
| abstract_inverted_index.five | 112 |
| abstract_inverted_index.most | 104 |
| abstract_inverted_index.that | 148 |
| abstract_inverted_index.this | 1 |
| abstract_inverted_index.type | 21, 152 |
| abstract_inverted_index.well | 50 |
| abstract_inverted_index.were | 37, 85 |
| abstract_inverted_index.with | 20, 88, 151 |
| abstract_inverted_index.2014, | 30 |
| abstract_inverted_index.Asahi | 43 |
| abstract_inverted_index.F-CPR | 156 |
| abstract_inverted_index.U-CPR | 158 |
| abstract_inverted_index.after | 66, 166 |
| abstract_inverted_index.among | 149 |
| abstract_inverted_index.index | 96 |
| abstract_inverted_index.other | 11, 105 |
| abstract_inverted_index.urine | 82 |
| abstract_inverted_index.while | 138 |
| abstract_inverted_index.ΔCPR | 93 |
| abstract_inverted_index.(CPI). | 97 |
| abstract_inverted_index.F-CPR, | 137 |
| abstract_inverted_index.HbA1c, | 89 |
| abstract_inverted_index.U-CPR. | 142 |
| abstract_inverted_index.affect | 14 |
| abstract_inverted_index.aging, | 118 |
| abstract_inverted_index.assess | 69 |
| abstract_inverted_index.factor | 110 |
| abstract_inverted_index.months | 65, 165 |
| abstract_inverted_index.namely | 115 |
| abstract_inverted_index.plasma | 76 |
| abstract_inverted_index.pooled | 81 |
| abstract_inverted_index.study, | 2 |
| abstract_inverted_index.(F-CPR) | 79 |
| abstract_inverted_index.(HbA1c) | 63 |
| abstract_inverted_index.(U-CPR) | 84 |
| abstract_inverted_index.Between | 25 |
| abstract_inverted_index.October | 26 |
| abstract_inverted_index.control | 17, 163 |
| abstract_inverted_index.disease | 70 |
| abstract_inverted_index.fasting | 75 |
| abstract_inverted_index.insulin | 8, 116, 121, 131, 139 |
| abstract_inverted_index.patient | 106, 127 |
| abstract_inverted_index.predict | 160 |
| abstract_inverted_index.admitted | 38 |
| abstract_inverted_index.affected | 141 |
| abstract_inverted_index.clinical | 12 |
| abstract_inverted_index.contrast | 91 |
| abstract_inverted_index.control, | 48, 125 |
| abstract_inverted_index.diabetes | 23, 34, 57, 154 |
| abstract_inverted_index.factors, | 114 |
| abstract_inverted_index.glycated | 61 |
| abstract_inverted_index.glycemic | 16, 47, 124, 162 |
| abstract_inverted_index.hospital | 41 |
| abstract_inverted_index.improved | 161 |
| abstract_inverted_index.indicate | 147 |
| abstract_inverted_index.measured | 60 |
| abstract_inverted_index.measures | 6 |
| abstract_inverted_index.patients | 19, 35, 150 |
| abstract_inverted_index.strongly | 101, 135 |
| abstract_inverted_index.training | 53 |
| abstract_inverted_index.C-peptide | 77, 95 |
| abstract_inverted_index.analysis, | 74, 111 |
| abstract_inverted_index.discharge | 67 |
| abstract_inverted_index.education | 55 |
| abstract_inverted_index.long-term | 15 |
| abstract_inverted_index.mellitus, | 155 |
| abstract_inverted_index.mellitus. | 24 |
| abstract_inverted_index.monitored | 32 |
| abstract_inverted_index.secretion | 9, 132, 140 |
| abstract_inverted_index.Foundation | 45 |
| abstract_inverted_index.associated | 87 |
| abstract_inverted_index.hemoglobin | 62 |
| abstract_inverted_index.influenced | 136 |
| abstract_inverted_index.resistance | 134 |
| abstract_inverted_index.secretion, | 122 |
| abstract_inverted_index.underlying | 113 |
| abstract_inverted_index.univariate | 73 |
| abstract_inverted_index.variables. | 107 |
| abstract_inverted_index.association | 99 |
| abstract_inverted_index.conclusion, | 144 |
| abstract_inverted_index.exploratory | 109 |
| abstract_inverted_index.independent | 102 |
| abstract_inverted_index.information | 13 |
| abstract_inverted_index.investigate | 4 |
| abstract_inverted_index.management. | 58, 71 |
| abstract_inverted_index.particular, | 130 |
| abstract_inverted_index.represented | 126 |
| abstract_inverted_index.resistance, | 117 |
| abstract_inverted_index.differences, | 120 |
| abstract_inverted_index.significantly | 86 |
| abstract_inverted_index.characteristics. | 128 |
| abstract_inverted_index.hospitalization. | 167 |
| abstract_inverted_index.immunoreactivity | 78 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5106134531, https://openalex.org/A5087631777, https://openalex.org/A5111691008, https://openalex.org/A5101677092, https://openalex.org/A5026766293, https://openalex.org/A5076072349, https://openalex.org/A5113655712, https://openalex.org/A5065980264, https://openalex.org/A5081065831, https://openalex.org/A5087983151, https://openalex.org/A5090154490 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| corresponding_institution_ids | https://openalex.org/I4210087332 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5899999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.86660368 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |